UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 731

Sortiert nach

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

The Journal of immunology (1950), 2017-01, Vol.198 (2), p.927-936

2017

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.180-180, Article 180

2019

Volltextzugriff (PDF)

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Molecular cancer, 2018-02, Vol.17 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Cancers, 2024-01, Vol.16 (3), p.606

2024

Volltextzugriff (PDF)

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell death & disease, 2020-07, Vol.11 (7), p.581, Article 581

2020

Volltextzugriff (PDF)

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Journal of immunotherapy, 2009-06, Vol.32 (5), p.498-507

2009

Volltextzugriff (PDF)

Development of an Image Analysis-Based Prognosis Score Using Google's Teachable Machine in Melanoma

Cancers, 2022-04, Vol.14 (9), p.2243

2022

Volltextzugriff (PDF)

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

PloS one, 2011, Vol.6 (8), p.e23429

2011

Volltextzugriff (PDF)

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

European journal of nuclear medicine and molecular imaging, 2018-01, Vol.45 (1), p.95-101

2018

Volltextzugriff (PDF)

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Clinical cancer research, 2017-10, Vol.23 (20), p.6203-6214

2017

Volltextzugriff (PDF)

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Acta dermato-venereologica, 2022-01, Vol.102, p.adv00637-adv00637

2022

Volltextzugriff (PDF)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

PloS one, 2019-08, Vol.14 (8), p.e0221301-e0221301

2019

Volltextzugriff (PDF)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

Cancers, 2020-02, Vol.12 (3), p.540

2020

Volltextzugriff (PDF)

The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review

Radiologia medica, 2022-07, Vol.127 (7), p.773-783

2022

Volltextzugriff (PDF)

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Cancers, 2021-07, Vol.13 (15), p.3864

2021

Volltextzugriff (PDF)

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Cancers, 2020-09, Vol.12 (9), p.2359

2020

Volltextzugriff (PDF)

Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer

Acta dermato-venereologica, 2020-11, Vol.100 (18), p.adv00328-adv00328

2020

Volltextzugriff (PDF)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.343-343, Article 343

2019

Volltextzugriff (PDF)

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2313-2321

2020

Volltextzugriff (PDF)

Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study

Cancers, 2021-05, Vol.13 (11), p.2642

2021

Volltextzugriff (PDF)

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

Journal of experimental & clinical cancer research, 2024-01, Vol.43 (1), p.30-22, Article 30

2024

Volltextzugriff (PDF)

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

PloS one, 2013-11, Vol.8 (11), p.e81624-e81624

2013

Volltextzugriff (PDF)

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Targeted oncology, 2021-03, Vol.16 (2), p.197-205

2021

Volltextzugriff (PDF)

26 – 50 von 731

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(682)
Mit Volltextzugriff
(657)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(682)
Japanisch
(69)
Deutsch
(67)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Development of an Image Analysis-Based Prognosis Score Using Google's Teachable Machine in Melanoma

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Aktive Filter

Suchergebnisse filtern